Cassava Sciences Inc (SAVA)
25.86
-0.35
(-1.34%)
USD |
NASDAQ |
Nov 04, 12:54
Cassava Sciences Shareholders Equity (Quarterly): 188.97M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 188.97M |
March 31, 2024 | 78.60M |
December 31, 2023 | 137.47M |
September 30, 2023 | 155.12M |
June 30, 2023 | 179.35M |
March 31, 2023 | 204.00M |
December 31, 2022 | 227.54M |
September 30, 2022 | 198.72M |
June 30, 2022 | 218.37M |
March 31, 2022 | 237.09M |
December 31, 2021 | 253.92M |
September 30, 2021 | 267.56M |
June 30, 2021 | 276.48M |
March 31, 2021 | 281.19M |
December 31, 2020 | 92.20M |
September 30, 2020 | 23.97M |
June 30, 2020 | 24.18M |
March 31, 2020 | 24.83M |
December 31, 2019 | 22.10M |
September 30, 2019 | 17.44M |
June 30, 2019 | 17.82M |
March 31, 2019 | 18.55M |
December 31, 2018 | 19.63M |
September 30, 2018 | 19.97M |
June 30, 2018 | 8.546M |
Date | Value |
---|---|
March 31, 2018 | 10.30M |
December 31, 2017 | 9.699M |
September 30, 2017 | 11.37M |
June 30, 2017 | 13.27M |
March 31, 2017 | 16.72M |
December 31, 2016 | 18.64M |
September 30, 2016 | 20.32M |
June 30, 2016 | 22.99M |
March 31, 2016 | 25.28M |
December 31, 2015 | 29.37M |
September 30, 2015 | 33.07M |
June 30, 2015 | 35.94M |
March 31, 2015 | 38.44M |
December 31, 2014 | 40.06M |
September 30, 2014 | 41.21M |
June 30, 2014 | 43.65M |
March 31, 2014 | 45.70M |
December 31, 2013 | 48.30M |
September 30, 2013 | 14.25M |
June 30, 2013 | 14.18M |
March 31, 2013 | 13.41M |
December 31, 2012 | 13.14M |
September 30, 2012 | 46.33M |
June 30, 2012 | 46.17M |
March 31, 2012 | 45.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
22.10M
Minimum
Dec 2019
281.19M
Maximum
Mar 2021
162.72M
Average
188.97M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 17.14B |
Eli Lilly and Co | 14.24B |
Seelos Therapeutics Inc | -28.13M |
Biomarin Pharmaceutical Inc | 5.413B |
EyePoint Pharmaceuticals Inc | 228.30M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 243.57M |
Total Liabilities (Quarterly) | 54.59M |